Vacciguard Novel Vaccines

VacciGuard's technology addresses two large potential markets - the market of preventive vaccines for infectious diseases and the market for therapeutic vaccines for lung cancer.

The annual world market for preventive vaccines for infectious diseases is estimated at $1.1 billion.

The annual world market for lung cancer vaccines (non- small -cell cancer alone) is estimated at $3.7 billion.